Scarica l'app Stockscreener
1.22
4.27%
0.05
Precedente Chiudi:
$1.17
Aprire:
$1.16
Volume 24 ore:
76,950
Relative Volume:
0.38
Capitalizzazione di mercato:
$155.26M
Reddito:
-
Utile/perdita netta:
$-18.43M
Rapporto P/E:
-7.8306
EPS:
-0.1558
Flusso di cassa netto:
$-12.87M
1 W Prestazione:
-4.69%
1M Prestazione:
-1.61%
6M Prestazione:
-18.67%
1 anno Prestazione:
-20.26%
Intervallo 1D:
$1.16
$1.24
Intervallo di 1 settimana:
$1.13
$1.32
Portata 52W:
$1.04
$2.60
Tiziana Life Sciences Ltd Stock (TLSA) Company Profile
Nome
Tiziana Life Sciences Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Compare TLSA vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TLSA
Tiziana Life Sciences Ltd
|
1.22 | 166.71M | 0 | -18.43M | -12.87M | -0.1558 |
VRTX
Vertex Pharmaceuticals Inc
|
523.70 | 134.02B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.02 | 68.59B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
925.11 | 58.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
317.89 | 41.76B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.48 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-12-22 | Iniziato | B. Riley Securities | Buy |
| 2018-12-17 | Iniziato | Laidlaw | Buy |
Tiziana Life Sciences Ltd Borsa (TLSA) Ultime notizie
Price to sales forward of Tiziana Life Sciences Ltd – NASDAQ:TLSA - TradingView
Tiziana Life Sciences Ltd. Actuals & Estimates (DUS:0RP) - TradingView
Tiziana Life Sciences Ltd. Actuals & Estimates (NASDAQ:TLSA) - TradingView
Tiziana Life Sciences Ltd. Actuals & Estimates (FWB:0RP) - TradingView
TLSA Forecast — Price Target — Prediction for 2027 - TradingView
Tiziana Life Sciences Ltd. Actuals & Estimates (TRADEGATE:0RP) - TradingView
Small cap wrap: Power Metallic Mines, Tiziana Life Sciences, Fox Tungsten, American Resources… - Proactive financial news
0RP Forecast — Price Target — Prediction for 2027 - TradingView
Could Intranasal Innovation Shape the Future of Multiple Sclerosis Care? - Kalkine Media
Tiziana Life Sciences doses last patient in Phase 2a multiple sclerosis trial - Yahoo! Finance Canada
Tiziana Life Sciences (TLSA) Advances Clinical Trial for Multiple Sclerosis Treatment - GuruFocus
Tiziana Life Sciences Doses Last Patient in Phase 2 Trial of Potential Multiple Sclerosis Treatment - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
Tiziana (Nasdaq: TLSA) completes enrollment in Phase 2a INFORM-MS study - Stock Titan
Tiziana Life Sciences Ltd. - Via Ritzau
Tiziana Life Sciences Ltd (TLSA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Tiziana Life Sciences Ltd (TLSA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tiziana Life Sciences Ltd (TLSA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Tiziana Life Sciences Ltd (TLSA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Why Tiziana Life Sciences Is Back on the Small-Cap Radar? - Kalkine Media
Tiziana Life Sciences Ltd (TLSA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Tiziana Life Sciences Ltd (TLSA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tiziana Life Sciences Ltd (TLSA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Tiziana Life Sciences Ltd (TLSA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Tiziana Life Sciences Ltd (TLSA) Institutional Confidence - TradingKey
Tiziana Life Sciences (TLSA) insider awarded 15,000 common shares - Stock Titan
Tiziana Life Sciences Chair Boosts Stake as Foralumab Trials Advance - The Globe and Mail
Tiziana Life Sciences Ltd announced that it has received $0.01665 million in funding - marketscreener.com
Tiziana Life Sciences (TLSA) Executive Chairman Boosts Stake wit - GuruFocus
Tiziana Life Sciences (TLSA) Executive Chairman Boosts Shareholding - GuruFocus
Tiziana executive chairman increases stake - Proactive financial news
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman - The Manila Times
Tiziana (NASDAQ: TLSA) chair lifts stake with 15,000-share purchase - Stock Titan
Founder now owns 34.89% of Tiziana Life Sciences after 15K-share buy - Stock Titan
Tiziana Life Sciences (TLSA) Retreats 2.6% as Shares Approach Key SupportGolden Cross - newsline.com
[6-K] Tiziana Life Sciences Ltd Current Report (Foreign Issuer) | TLSA SEC FilingForm 6-K - Stock Titan
Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York - NTB Kommunikasjon
Tiziana Life Sciences to present clinical updates at Jefferies healthcare conference - Proactive financial news
Biotech Tiziana to brief investors on clinical updates at Jefferies event - Stock Titan
Tiziana Life Sciences (TLSA) Slips 2.65% as Stock Tests Key Support ZoneVolume Oscillator - The Legal Advocate
TLSATiziana Life Sciences Ltd Stock Price and Quote - Finviz
Tiziana Life Sciences (TLSA) COO discloses Form 3 share and option holdings - Stock Titan
Tiziana Life Sciences advances foralumab program with full Phase 2 enrollment and encouraging expanded access data – ICYMI - Yahoo! Finance Canada
Tiziana Life Sciences completes enrollment in Phase 2a trial for multiple sclerosis drug foralumab - Pluang
Tiziana Life Sciences (TLSA) Completes Patient Enrollment in Cli - GuruFocus
Tiziana completes enrollment for Phase 2 trial in progressive MS study - Proactive financial news
Why Is TLSA Stock Rising Today? - Stocktwits
Tiziana Life Sciences completes enrollment in Phase 2a multiple sclerosis trial - Yahoo! Finance Canada
Tiziana Fully Enrolls its Phase 2 Placebo Controlled Multiple Sclerosis Trial - The Manila Times
Phase 2a MS trial fully enrolled at Tiziana Life Sciences (NASDAQ: TLSA) - Stock Titan
Tiziana Life Sciences Shares Drop After Company Unveils Plan to Spin Out IL-6 Program - MSN
Tiziana Life Sciences Ltd Azioni (TLSA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.60%
3.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):